Annual reports
Our annual reports can be found and downloaded here.
![Annual Report 2023 (1)](/media/usbnftwy/annual-report-2023.png?mode=max&width=290&rnd=133576532417830000)
2023 Annual Report
During the year 2023, Sedana Medical took several important steps towards becoming a stronger and healthier company. We have returned to consistent sales growth after the challenging post-Covid period, we have taken decisive steps towards reaching profitability in our ex-US business, and we are making progress towards our launch on the US market – our single largest growth opportunity and a pivotal milestone for the company.
![Annual Report 2022 Front Page](/media/fedj3n10/annual-report-2022-front-page.png?mode=max&width=290&rnd=133249998704230000)
2022 Annual Report
In 2022, Sedana Medical took several important steps closer to our vision – to make inhaled sedation a global standard therapy for mechanically ventilated patients in intensive care.
![Annual Report 2021](/media/y2ofqajr/framsida-år-2021-en.jpg?mode=max&width=290&rnd=132938015968830000)
2021 Annual Report
Sedana Medical reached an important milestone in 2021, when the pharmaceutical product Sedaconda (isoflurane), and consequently inhaled sedation therapy, received European market approval.
![Annual Report 2020](/media/plvk1ayv/annual-report-2020-en.png?mode=max&width=290&rnd=132938015968970000)
2020 Annual report
During the year, Sedana Medical was greatly impacted by the pandemic, which resulted in a significant rise in sales but also increased awareness of the company and interest in inhaled sedation.
![Annual Report 2019](/media/jbldxiw0/annual-report-2019-en.png?mode=max&width=290&rnd=132938015969170000)
2019 Annual Report
![Annual Report 2018](/media/t5ipqb1n/annual-report-2018-en.png?mode=max&width=290&rnd=132938015969530000)
2018 Annual Report
![Annual Report 2017](/media/mm1hx4cv/annual-report-2017-en.png?mode=max&width=290&rnd=132938015969330000)